Manage Your Liver
Q:

More and more patients are dying of liver cancer. Change now to avoid becoming the next victim!

More and more patients are dying of liver cancer. Change now to avoid becoming the next victim!
A:

A recent report released by the US National Cancer Institute showed that among the top ten deadliest cancers, liver cancer is killing the most people. Over the past 10 years, the number of deaths caused by liver cancer has increased by 2.2% (women) and 2.8% (men) every year. The main causes for liver cancer are cirrhosis caused by hepatitis C, alcohol abuse, diabetes and obesity. [1]

 

These figures imply that in the past decade, the treatment of liver diseases is simply unsatisfactory, and the methods currently used to prevent liver cancer are also ineffective. In fact, the current treatment methods are actually increasing patients’ risk of getting liver cancer!

 

The modern approach to preventing liver cancer is to treat liver diseases that might lead to liver cancer with a variety of drugs. Other than this, there are no other commonly used preventive measures for liver cancer. But how many people have come to realise that drugs themselves are harmful to liver cells and liver function? In fact, many cases of liver cancer are caused by the excessive use of drugs. Nowadays, we are often prescribed with different drugs to treat chronic diseases, however these sorts of drugs are chemicals, use in short term it can be very effective, but use in long term, they are all likely to harm liver cells. [2]

 

In order to reduce the chance of liver cancer and lower the death rate of liver cancer in the future, we must revaluate the current approach and find better ways to treat liver diseases. The top priority and main objective in treating liver diseases should be to protect liver cells, and enhance liver function! This is the only method to ensure a healthy liver and prevent liver cancer!

Image from: www.cancer.gov

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us